Updated Jul 16, 2026 · Last SEC filing 2026-07-06
Vaxcyte, Inc. (PCVX) has filed 16 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-06. 4 Form 8-K material event filings were reported by PCVX in the last 90 days. 7 Form 144 notices of proposed sale were filed for PCVX stock. InsiderAlpha tracks every PCVX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001649094 |
|---|
| Form 4 filings (90d) | 16 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 7 |
| Latest Form 4 filing | 2026-07-06 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO | S — Open-market sale | 7.9K | $57.16 | $452K | SEC | |
| GUGGENHIME ANDREW | PRESIDENT AND CFO | M — Option exercise | 10.0K | $5.35 | $54K | SEC | |
| GUGGENHIME ANDREW | PRESIDENT AND CFO | S — Open-market sale | 2.1K | $57.76 | $121K | SEC | |
| Wassil Jim | CHIEF OPERATING OFFICER | S — Open-market sale | 6 | $57.82 | $347 | SEC | |
| Wassil Jim | CHIEF OPERATING OFFICER | M — Option exercise | 516 | $5.35 | $3K | SEC | |
| Wassil Jim | CHIEF OPERATING OFFICER | S — Open-market sale | 1.8K | $56.03 | $100K | SEC | |
| Wassil Jim | CHIEF OPERATING OFFICER | S — Open-market sale | 456 | $57.47 | $26K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 332 | $55.99 | $19K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 207 | $54.22 | $11K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 312 | $54.34 | $17K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 191 | $56.27 | $11K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 9.1K | $55.27 | $505K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 6.4K | $56.12 | $360K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 356 | $55.23 | $20K | SEC | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 6.7K | $54.27 | $363K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Vaxcyte, Inc. (PCVX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| PICKERING GRANT | 15 | $2.62M |
| Wassil Jim | 8 | $369K |
| GUGGENHIME ANDREW | 7 | $1.21M |
| Paya Carlos V | 2 | — |
| BRANDICOURT OLIVIER | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PCVX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PCVX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.